STEPHEN BEAUPRE: Open Payments
NPI 1619994217 · WARWICK, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$879 in 37 payments from 10 companies in 2025. Trend: 2023 $937 · 2024 $779 · 2025 $879
Food & beverage: $879
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $206 |
| GlaxoSmithKline, LLC. | 11 | $197 |
| PFIZER INC. | 4 | $86 |
| HARMONY BIOSCIENCES LLC | 1 | $81 |
| Exact Sciences Corporation | 3 | $65 |
| ABBVIE INC. | 3 | $60 |
| Lilly USA, LLC | 2 | $58 |
| Abbott Laboratories | 2 | $51 |
| Novo Nordisk Inc | 2 | $47 |
| Actelion Pharmaceuticals US, Inc. | 1 | $26 |
Products named: TRELEGY ELLIPTA, FARXIGA, WAKIX, Cologuard Collection Kit, MOUNJARO, AIRSUPRA, FREESTYLE LIBRE 3, UBRELVY.
Industry payments across RI — which companies pay providers there.
